- Home
- LPL vs ZLAB Comparison
LPL vs ZLAB Comparison
Compare LPL & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPL
- ZLAB
- Stock Information
- Founded
- LPL 1985
- ZLAB 2013
- Country
- LPL South Korea
- ZLAB China
- Employees
- LPL N/A
- ZLAB N/A
- Industry
- LPL Industrial Machinery/Components
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- LPL Technology
- ZLAB Health Care
- Exchange
- LPL Nasdaq
- ZLAB Nasdaq
- Market Cap
- LPL 3.4B
- ZLAB 4.0B
- IPO Year
- LPL 2004
- ZLAB 2017
- Fundamental
- Price
- LPL $4.46
- ZLAB $30.76
- Analyst Decision
- LPL Sell
- ZLAB Buy
- Analyst Count
- LPL 2
- ZLAB 6
- Target Price
- LPL N/A
- ZLAB $57.22
- AVG Volume (30 Days)
- LPL 621.2K
- ZLAB 511.6K
- Earning Date
- LPL 10-22-2025
- ZLAB 08-07-2025
- Dividend Yield
- LPL N/A
- ZLAB N/A
- EPS Growth
- LPL N/A
- ZLAB N/A
- EPS
- LPL N/A
- ZLAB N/A
- Revenue
- LPL $19,437,582,152.00
- ZLAB $427,799,000.00
- Revenue This Year
- LPL N/A
- ZLAB $42.62
- Revenue Next Year
- LPL $0.91
- ZLAB $55.12
- P/E Ratio
- LPL N/A
- ZLAB N/A
- Revenue Growth
- LPL 8.96
- ZLAB 32.56
- 52 Week Low
- LPL $2.43
- ZLAB $19.16
- 52 Week High
- LPL $4.97
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- LPL 60.79
- ZLAB 37.68
- Support Level
- LPL $4.24
- ZLAB $28.71
- Resistance Level
- LPL $4.48
- ZLAB $33.97
- Average True Range (ATR)
- LPL 0.10
- ZLAB 1.17
- MACD
- LPL -0.01
- ZLAB -0.39
- Stochastic Oscillator
- LPL 92.86
- ZLAB 25.43
About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.